The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

The Sackler family and Purdue Pharma have agreed to pay $7.4 billion to resolve nationwide opioid litigation, marking a major ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...

The Sackler family and Purdue Pharma agreed to pay $7.4 billion to settle lawsuits over the toll of the powerful prescription ...

The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.

Sackler family, who owned pharmaceutical company Purdue Pharma, will no longer be in control of the company or permitted to sell opioids if the new settlement plan is approved ...

Pennsylvania may receive up to $212 million over 15 years as part of a multi-state lawsuit settlement with Purdue Pharma and ...

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

Pennsylvania expects to receive $212 million over 15 years as part of a multi-state settlement with the Sackler family.